| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.003 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.004 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.004 |